Premium
Letter: treatment of HBeAg+ chronic hepatitis B – is tenofovir truly superior to entecavir? Authors' reply
Author(s) -
Gao L.,
Trinh H. N.,
Li J.,
Nguyen M. H.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12765
Subject(s) - entecavir , tenofovir , medicine , viral load , clinical trial , chronic hepatitis , hbeag , antiviral treatment , hepatitis b virus , virology , human immunodeficiency virus (hiv) , lamivudine , virus , hbsag
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom